MedRx Co., Ltd (TYO:4586)
Japan
· Delayed Price · Currency is JPY 62.00
+1.00 (1.64%)
May 16, 2025, 3:30 PM JST
MedRx Revenue
MedRx had revenue of 2.00M JPY in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to 259.00M, up 1,026.09% year-over-year. In the year 2024, MedRx had annual revenue of 257.00M with 786.21% growth.
Revenue (ttm)
259.00M
Revenue Growth
+1,026.09%
P/S Ratio
11.37
Revenue / Employee
11.77M
Employees
22
Market Cap
2.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 257.00M | 228.00M | 786.21% |
| Dec 31, 2023 | 29.00M | -30.00M | -50.85% |
| Dec 31, 2022 | 59.00M | 51.00M | 637.50% |
| Dec 31, 2021 | 8.00M | -107.00M | -93.04% |
| Dec 31, 2020 | 115.00M | -54.00M | -31.95% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 869.37B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |